Chronic Familial Neutropenia Latest Advances
Find the Latest Research About Chronic Familial Neutropenia
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1292 publications
Phlegmonous Gastritis in a Profoundly Neutropenic Patient With Chronic Myeloid Leukemia.
Journal: Gastro hep advances
Published: April 07, 2026
Fulminant septic shock from clinically occult deep soft tissue infection in chronic lymphedema: A clinicopathological correlation.
Journal: IDCases
Published: March 20, 2026
Synchronous Presentation of Chronic Myelomonocytic Leukemia and Multiple Myeloma in a Treatment-Naïve Patient.
Journal: Case reports in hematology
Published: March 05, 2026
A Comprehensive Review of the Role of Zanubrutinib for Patients with Chronic Lymphocytic Leukemia.
Journal: Oncology and therapy
Published: January 28, 2026
Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.
Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.
Journal: Acta haematologica
Published: January 21, 2026
Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.
Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.
Journal: Acta haematologica
Published: January 21, 2026
Personalized Management of Cytopenias in Chronic Liver Disease: From Pathophysiology to Treatment Strategies.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: January 20, 2026
Bendamustine/Rituximab Induction Followed by Venetoclax/Rituximab Consolidation in Frontline Treatment of Chronic Lymphocytic Leukemia: A Phase 2 Multi-Center Study.
Journal: Hematological oncology
Published: January 06, 2026
Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-Analysis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 30, 2025
Chronic Kidney Disease-Associated Defect in Humoral Immune Response Is Driven by Inflammation.
Journal: Toxins
Published: December 18, 2025
Oral CXCR4 inhibition with mavorixafor: Emerging therapeutic applications in WHIM syndrome, chronic neutropenia, oncology, and stem cell mobilization.
Journal: Current research in translational medicine
Published: November 13, 2025
Last Updated: 06/30/2026